Efficient neurophysiologic selection of X-linked Charcot-Marie-Tooth families: Ten novel mutations

Neurology

Volumn 51, Issue 5, 1998, Pages 1412-1416

  Nicholson, Garth A ^a   Yeung, Leone ^a   Corbett, Alistair ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN;

ADULT; ARTICLE; CHROMOSOME 17; CLINICAL ARTICLE; EVOKED AUDITORY RESPONSE; EVOKED BRAIN STEM RESPONSE; GENE DUPLICATION; GENE MUTATION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC SCREENING; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; NERVE CONDUCTION; PREVALENCE; PRIORITY JOURNAL;

EID: 0031797442     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.5.1412     Document Type: Article

References (29)

1. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth disease. Clin Genet 1974;6:98-118.
2. MacMillan JC, Harper PS. The Charcot-Marie-Tooth syndrome: clinical aspects from a population study in South Wales, UK. Clin Genet 1994;45:128-134.
3. Emery AEH. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscul Disord 1991;1: 19-29.
4. Chance PF, Abbas N, Lensch MW, et al. Two autosomal dominant neuropathies result from reciprocal DNA duplication/ deletion of a region on chromosome 17. Hum Mol Genet 1994; 3:223-228.
5. Nelis E, Van Broeckhoven C, De Jonghe P, et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type one and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 1996; 4:25-33.
6. Valentijn LJ, Baas F, Wolterman RA, et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;2:288-291.
7. Roa BB, Garcia CA, Suter U, et al. Charcot-Marie-Tooth disease type 1A association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993;329:96-101.
8. Roa BB, Dyck PJ, Marks HG, Chance PF, Lupski JR. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 1993;5:269-272.
9. Valentijn LJ, Ouvrier RA, van den Bosch NHA, Bolhuis PA, Baas F, Nicholson GA. Dejerine-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum Mutat 1995;5: 76-80.
10. Nelis E, Timmerman V, De Jonghe P, Van Broeckhoven C. Identification of a 5÷ splice site mutation in the PMP-22 gene in autosomal dominant Charcot-Marie-Tooth disease type one. Hum Mol Genet 1994;3:515-516.
11. Navon R, Seifried B, Gal-On NS, Sadeh M. A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe, de novo Charcot-Marie-Tooth disease. Hum Genet 1996;97:685-687.
12. Nicholson G, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 1993;43:2558-2564.
13. Hayasaka K, Himoro M, Sato W, et al. Charcot-Marie-Tooth type 1B is associated with mutations of the myelin Po gene. Nat Genet 1993;5:31-34.
14. Kulkens T, Bolhuis PA, Wolterman RA, et al. Deletion of the serine 34 codon from the major peripheral myelin Po gene in Charcot-Marie-Tooth disease type 1B. Nat Genet 1993;5: 35-39.
15. Rouger H, LeGuern E, Goudier R, et al. High frequency of mutations in codon 98 of the peripheral myelin protein Po gene in 20 French CMT1 patients. Am J Hum Genet 1996;58: 638-641.
16. Warner LA, Hilz MJ, Appel SH, et al. Clinical phenotypes of different MPZ (Po) mutations may include Charcot-Marie-Tooth 1B, Dejerine-Sottas and congenital hypomyelination. Neuron 1996;17:451-460.
17. Roa BB, Warner LE, Garcia CA, et al. Myelin protein zero (MPZ) gene mutations in nonduplication type one Charcot-Marie-Tooth disease. Hum Mutat 1996;7:36-45.
18. Bergoffen J, Scherer SS, Wang S, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993;262: 2039-2042.
19. Bone LJ, Dahl BA, Lensch BS, et al. New connexin 32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology 1995;45:1863-1866.
20. Dermietzel R, Spray DC. Gap-junctions in the brain: where, what type, how many and why? Trends Neurosci 1993;16: 186-192.
21. Nicholson G, Corbett A. Slowing of central conduction in X-linked Charcot-Marie-Tooth neuropathy shown by brainstem auditory evoked responses. J Neurol Neurosurg Psychiatry 1996;61:43-46.
22. Nicholson G, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 1996;43:2558-2564.
23. Kennerson ML, Gordon MJ, Blair IP, Nicholson GA. Single test for two hereditary neuropathies, CMT1A and HNPP. Clin Chem 1995;41:1-3.
24. Hovig E, Smith-Sorensen B, Brogger A, Borresen AL. Constant denaturant gel electrophoresis, a modification of denaturant gradient gel electrophoresis in mutation detection. Mutat Res 1991;262:63-71.
25. Lerman LS, Silverstein K. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol 1987;155:482-501.
26. Andersen TI, Borrensen AL. Alterations of the TP53 gene as a potential prognostic marker in breast carcinomas. Advantages of using constant denaturant gel electrophoresis in mutation detection. Diagn Mol Pathol 1995;4:203-211.
27. Ionasescu VV, Searby C, Ionasescu R, Neuhaus I, Werner R. Mutations of the noncoding region of the connexin 32 gene in X-linked Charcot-Marie-Tooth neuropathy. Neurology 1996; 46:A173.
28. Ohnishi A, Li LY, Fukushima Y, Mori T, et al. Asian hereditary neuropathy patients with peripheral myelin protein-22 gene aneuploidy. Am J Med Genet 1995;59:51-58.
29. Janssen EAM, Kemp S, Hensels GW, et al. Connexin 32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Genet 1997;99:501-505.